Blog

Peptide research insights, sourcing guides, laboratory applications, quality standards, and industry trends. Explore expert articles designed for research professionals worldwide.

RT10 peptide 4

Peptides en France: 2026 Guide to Research Peptides, Quality Testing & Reliable Suppliers

Interest in peptides en France now extends well beyond a single scientific field. French universities, biotechnology teams, analytical laboratories, and life-science companies use synthetic peptides in molecular biology, assay development, reference-material studies, and early-stage research. However, finding a peptide is…

Read MorePeptides en France: 2026 Guide to Research Peptides, Quality Testing & Reliable Suppliers
How to use retatrutide

How to Use Retatrutide: What Clinical Trials Show About Dosing, Safety, Results, and Proper Use

Retatrutide has become one of the most closely watched investigational medicines in metabolic research. Search interest has grown rapidly because clinical trials have reported substantial reductions in body weight. However, the phrase “how to use retatrutide” needs an important explanation…

Read MoreHow to Use Retatrutide: What Clinical Trials Show About Dosing, Safety, Results, and Proper Use
tesamorelin for sale

Tesamorelin Research: GHRH Mechanism, IGF-1 Pathway, Visceral Fat, Liver Studies & Laboratory Data

Tesamorelin is a synthetic growth hormone-releasing hormone peptide derived from the 44-amino-acid sequence of human growth hormone-releasing hormone, also called GHRH or GRF. A hexenoyl modification at the N-terminal tyrosine improves resistance to enzymatic degradation while preserving activity at the…

Read MoreTesamorelin Research: GHRH Mechanism, IGF-1 Pathway, Visceral Fat, Liver Studies & Laboratory Data
RT20mg

Retatrutide Research: Triple GIP/GLP-1/Glucagon Mechanisms, Phase 3 Evidence, and Laboratory Applications

Retatrutide, also known as LY3437943, is a synthetic peptide engineered to activate three metabolically important receptors: the glucose-dependent insulinotropic polypeptide receptor (GIPR), glucagon-like peptide-1 receptor (GLP-1R), and glucagon receptor (GCGR). This triple-receptor profile distinguishes retatrutide from single GLP-1 agonists and…

Read MoreRetatrutide Research: Triple GIP/GLP-1/Glucagon Mechanisms, Phase 3 Evidence, and Laboratory Applications
Tirzepatide

Tirzepatide Research: Molecular Mechanisms, Dual GIP/GLP-1 Signaling, and Laboratory Evidence

Tirzepatide is a synthetic, long-acting peptide engineered to activate both the glucose-dependent insulinotropic polypeptide receptor, or GIPR, and the glucagon-like peptide-1 receptor, or GLP-1R. Researchers study it because this single molecule links two incretin signaling systems while showing distinct receptor…

Read MoreTirzepatide Research: Molecular Mechanisms, Dual GIP/GLP-1 Signaling, and Laboratory Evidence